| 1.02 0.09 (9.68%) | 05-24 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.69 | 1-year : | 0.86 |
| Resists | First : | 0.59 | Second : | 0.74 |
| Pivot price | 0.5  |
|||
| Supports | First : | 0.37 | Second : | 0.3 |
| MAs | MA(5) : | 0.47  |
MA(20) : | 0.53 |
| MA(100) : | 0.72 |
MA(250) : | 0.71 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 39.7 |
D(3) : | 33.7 |
| RSI | RSI(14): 40.3 |
|||
| 52-week | High : | 1.5 | Low : | 0.35 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ YS ] has closed above bottom band by 43.6%. Bollinger Bands are 13.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.54 - 0.54 | 0.54 - 0.55 |
| Low: | 0.42 - 0.43 | 0.43 - 0.43 |
| Close: | 0.49 - 0.49 | 0.49 - 0.49 |
YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. It develops a proprietary PIKA immunomodulating technology platform and a series of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, and Shingles. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.
Thu, 17 Oct 2024
YS Biopharma (YSB) Stock Price, News & Analysis - MarketBeat
Fri, 27 Sep 2024
LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation - PR Newswire
Fri, 27 Sep 2024
LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation - StockTitan
Thu, 05 Sep 2024
LakeShore changes CEO with new executive appointments - The Pharma Letter
Mon, 27 May 2024
YS Biopharma Co., Ltd. will Change its Ticker to LSB from YS - Marketscreener.com
Fri, 24 May 2024
YS Biopharma Announces Name Change to LakeShore Biopharma - PR Newswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 188 (M) |
| Shares Float | 17 (M) |
| Held by Insiders | 81.4 (%) |
| Held by Institutions | 2.8 (%) |
| Shares Short | 39 (K) |
| Shares Short P.Month | 96 (K) |
| EPS | -0.57 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 5.09 |
| Profit Margin | -66.8 % |
| Operating Margin | -49.5 % |
| Return on Assets (ttm) | -10.2 % |
| Return on Equity (ttm) | -77.9 % |
| Qtrly Rev. Growth | -9.2 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 2.88 |
| EBITDA (p.s.) | -1.58 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -0.88 |
| PEG Ratio | 0 |
| Price to Book value | 0.09 |
| Price to Sales | 0.16 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|